PRX and MYL Related Headlines
Go Back
-
Aug 24, 2012 08:05AM
Needham & Company Maintains a 'Hold' on Par Pharmaceutical (PRX); Is Endo (ENDP) the 'Mystery Bidder'
-
Aug 24, 2012 07:59AM
Needham & Company on Endo Pharmaceuticals (ENDP): Watson (WPI) Gains First Generic Lidoderm Approval; A Few Other Issues Too
-
Jul 20, 2012 08:31AM
Needham & Company maintains a 'Strong Buy' on Mylan (MYL); PRX Grossly Undervalued by TGP, MYL/PRX Instead As Strong Combo
-
Jul 18, 2012 10:26AM
Somaxon (SOMX) Shares Double on Silenor Settlement, Strong Sales Outlook
-
Jul 17, 2012 04:12PM
Somaxon (SOMX), Mylan (MYL), Par Pharma (PRX) Enter Silenor Settlement
-
Jul 17, 2012 04:11PM
Somaxon Pharmaceuticals (SOMX) Announces Settlement Agreement of Silenor Patent; Updates Revenues
-
Jul 16, 2012 02:39PM
Leerink Swann Downgrades Par Pharmaceutical (PRX) to Market Perform; Not Expecting Mylan (MYL) To Up The Ante
-
Jul 16, 2012 08:05AM
Par Pharmaceutical (PRX) Peers On Watch After Deal (TEVA) (MYL) (WPI)
PRX and MYL Related Press Releases
Go Back
PRX and MYL Related SEC Filings
Go Back